Holding(s) in Company

Arix Bioscience PLC (ARIX) Holding(s) in Company 24-Jan-2024 / 17:30 GMT/BST TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Arix Bioscience Plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer   2. Reason for the notification (please mark the appropriate box or boxes with an “X”) An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments   An event changing the breakdown of voting rights   Other (please specify) iii:   3. Details of person subject to the notification obligation iv Name RTW Investments, LP City and country of registered office (if applicable) New York, USA 4. Full name of shareholder(s) (if different from 3.) v Name RTW Biotech Opportunities Operating Ltd City and country of registered office (if applicable) St Peter Port, Guernsey 5. Date on which the threshold was crossed or reached vi: 17/01/2024 6. Date on which issuer notified (DD/MM/YYYY): 22/01/2024 7. Total positions of person(s) subject to the notification obligation   % of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer (8.A + 8.B) vii Resulting situation on the date on which threshold was crossed or reached 25.52 0.00% 25.52% 33,023,210 Position of previous notification (if applicable) n/a n/a n/a                   8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii A: Voting rights attached to shares Class/type of shares ISIN code (if possible) Number of voting rights ix % of voting rights Direct (DTR5.1) Indirect  (DTR5.2.1) Direct (DTR5.1) Indirect (DTR5.2.1) GB00BD045071 0 33,023,210 0.00% 25.52%                     SUBTOTAL 8. A 33,023,210 25.52%     B 1: Financial Instruments according to DTR5.3.1R (1) (a) Type of financial instrument Expiration date x Exercise/ Conversion Period xi Number of voting rights that may be acquired if the instrument is exercised/converted. % of voting rights                                   SUBTOTAL 8. B 1         B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) Type of financial instrument Expiration date x Exercise/ Conversion Period xi Physical or cash Settlement xii Number of voting rights % of voting rights                                           SUBTOTAL 8.B.2                               9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”) Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii   Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv   Name xv % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold Roderick Wong       RTW Investments GP LLC       RTW Investments, LP       RTW Biotech Opportunities Ltd       RTW Biotech Opportunities Operating Ltd 25.52% 0.00% 25.52%           10. In case of proxy voting, please identify: Name of the proxy holder   The number and % of voting rights held   The date until which the voting rights will be held     11. Additional information xvi               Place of completion London, UK Date of completion 19/01/2024             Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

ISIN:	GB00BD045071
Category Code:	HOL
TIDM:	ARIX
LEI Code:	213800OVT3AHQCXNIX43
OAM Categories:	2.3. Major shareholding notifications
Sequence No.:	299502
EQS News ID:	1822379

End of Announcement	EQS News Service